Intellect Neurosciences, Inc. (ILNS.OB) Obtains EU Patent for ANTISENILIN® Monoclonal Antibody
Intellect Neurosciences, Inc. (ILNS.OB), a development-stage biopharmaceutical company engaged in the discovery and development of therapeutic agents designed to slow,…